Covered recipient · General Payments record
FARIHA AHMED
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,538.08
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $352.00 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $185.48 | 9 |
| Shionogi Inc | $59.59 | 2 |
| PFIZER INC. | $26.35 | 1 |
| Melinta Therapeutics, Inc. | $23.80 | 1 |
| Merck Sharp & Dohme Corporation | $21.85 | 1 |
| CHIESI USA, INC. | $20.34 | 1 |
| Acerta Pharma LLC | $14.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.20 | 01/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185100 | CMS |
| ABBVIE INC. | $17.07 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185102 | CMS |
| ABBVIE INC. | $21.88 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185104 | CMS |
| ABBVIE INC. | $21.21 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185106 | CMS |
| ABBVIE INC. | $13.73 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185108 | CMS |
| ABBVIE INC. | $21.21 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185110 | CMS |
| ABBVIE INC. | $22.11 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185112 | CMS |
| ABBVIE INC. | $15.22 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185114 | CMS |
| ABBVIE INC. | $26.85 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103185116 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.59 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104234821 | CMS |
| Chiesi USA, Inc. | $20.34 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151799087 | CMS |
| Melinta Therapeutics, LLC | $23.80 | 11/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140484393 | CMS |
| Merck Sharp & Dohme LLC | $21.85 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141944395 | CMS |
| PFIZER INC. | $26.35 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131758930 | CMS |
| Shionogi Inc | $30.43 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154333970 | CMS |
| Shionogi Inc | $29.16 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154333980 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.